Bristol Myers Squibb
BMY· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Christopher S. Boerner is the CEO of Bristol Myers Squibb and was paid $21.9M in FY2025 (Dec), up 16%.
PayNo stock prices for these years
Executives6
See all- 1Christopher S. BoernerBoard Chair and Chief Executive OfficerFY2025
- 2Samit Hirawat, M.D.Former EVP, Chief Medical Officer, Head of DevelopmentFY2025
- 3Cristian MassacesiM.D. EVP, Chief Medical Officer, Head of DevelopmentFY2025
- 4Adam LenkowskyEVP, Chief Commercialization OfficerFY2025
- 5David V. ElkinsEVP and Chief Financial OfficerFY2025
- 6Greg MeyersEVP, Chief Digital and Technology OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBristol Myers Squibb paid its 6 named executives $68.0M in total in FY2025 (Dec). CEO Christopher S. Boerner was paid $21.9M of that.
| Name | |||
|---|---|---|---|
| Christopher S. BoernerBoard Chair and Chief Executive Officer | |||
| Samit Hirawat, M.D.Former EVP, Chief Medical Officer, Head of Development | |||
| Cristian MassacesiM.D. EVP, Chief Medical Officer, Head of Development | Not disclosed | Not disclosed | |
| Adam LenkowskyEVP, Chief Commercialization Officer | Not disclosed | Not disclosed | |
| David V. ElkinsEVP and Chief Financial Officer | |||
| Greg MeyersEVP, Chief Digital and Technology Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Bristol Myers Squibb. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
No new filings about this company in the feed.
Filings23
See all| Current report | 8-K | May 8, 2026 | — |
| Proxy statement | DEF 14A | Mar 25, 2026 | FY2025 |
| Annual report | 10-K | Feb 11, 2026 | FY2025 |
| Current report | 8-K | Jul 25, 2025 | — |
| Current report | 8-K | May 7, 2025 | — |
| Proxy statement | DEF 14A | Mar 26, 2025 | FY2024 |
